Search results (221)
« Back to NewsCollaborative research project awarded Pancreatic Cancer UK grant
24 April 2025
Academic Clinical Lecturer Mr Keaton Jones has been awarded a grant from Pancreatic Cancer UK to carry out pioneering pancreatic cancer research within the Nuffield Department of Surgical Sciences.
New biopsy technique found to improve prostate cancer detection
24 March 2025
Researchers from around the UK, led by the University of Oxford, have found that a new way of performing prostate biopsies is better at diagnosing prostate cancer, but takes longer to perform and is more painful for patients.
Study finds previously unidentified genetic determinants of rare disease
28 February 2025
A landmark study involving Oxford researchers, including Dr Sarah Howles from the Nuffield Department of Surgical Sciences, has identified 69 previously unidentified genetic determinants of rare disease, including uncommon forms of epilepsy and schizophrenia.
Digital health applications: How open, integrated feedback tools could improve safety and acceptance
4 February 2025
In a paper published today in Nature Medicine, an international team of researchers, including those from the University of Oxford and TUD Dresden University of Technology, show how user trust and pathways to market for digital health applications could be enhanced.
Oxford and GSK launch £50m immuno-prevention programme to advance novel cancer research
27 January 2025
Global biopharma company GSK invests up to £50 million in a collaboration with Oxford to advance the understanding of how cancer develops, which could inform future development of vaccines to prevent cancer.
Oxford tops Times Higher Education Subject Ranking Awards in Medicine for 14th Consecutive Year
24 January 2025
The University of Oxford has once again been named the top institution in the Times Higher Education (THE) Subject Rankings for Clinical, Pre-Clinical, and Health, marking an impressive 14th consecutive year in this prestigious position.
NIHR funded trauma project launched
17 January 2025
Oxford University Global Surgery Group has launched a new project on reducing childhood mortality and morbidity from injuries in Tanzania and Zimbabwe, funded by the National Institute for Health and Care Research (NIHR).
TRIG celebrates huge success at International Congress of The Transplantation Society
30 October 2024
The Translational Research Immunology Group (TRIG) at the Nuffield Department of Surgical Sciences has much to celebrate after winning five awards at the 30th International Congress of The Transplantation Society (TTS 2024) in Istanbul, Turkey, from 22 to 25 September.
Exploring science with us at IF Oxford
24 October 2024
During October, outreach teams from the Nuffield Department of Surgical Sciences once again participated in three events at IF Oxford Science + Ideas Festival.
ASPI honours ProtecT Trial for pioneering research demonstrating the safety of active surveillance
5 August 2024
The ProtecT Trial has been named the 2024 recipient of the Active Surveillance Patients International (ASPI) Special Award for game-changing research in the development of the Active Surveillance approach to managing low-risk prostate cancer.
Global Surgery DPhil student wins best presentation prize at BAPS 70th Anniversary Congress
29 July 2024
Dennis Mazingi, a DPhil student in Global Surgery, has won the David Lloyd Global Papers Prize at the 70th Annual Congress of the British Association of Paediatric Surgeons (BAPS) in Sheffield from 2-5 July 2024.
The second NDS Student Symposium held
23 July 2024
The Nuffield Department of Surgical Sciences (NDS) hosted its second annual NDS Student Symposium on Monday 1 July, held in the Richard Doll Building on Old Road Campus.
Three hospital trusts participating in an Oxford-led study evaluating AI software for diagnosing prostate cancer in clinical settings
22 July 2024
Oxford University Hospitals (OUH) NHS Foundation Trust, North Bristol NHS Trust, and University Hospitals Coventry and Warwickshire (UHCW) NHS Trust are evaluating a new Artificial Intelligence (AI) diagnostic system that could help improve prostate cancer diagnosis.
Catherine Lovegrove wins best presentation at international conference
3 July 2024
NDS DPhil student and MRC Clinical Research Training Fellow, Miss Catherine Lovegrove, was awarded 'Best Presentation' in the session 'Stones / Imaging / Upper Tract Disorders 2' at the 2024 BAUS Annual Scientific Meeting, held in Birmingham from 24 to 26 June.
Professor Tipu Aziz receives inaugural lifetime achievement award
13 June 2024
We are pleased to announce that Professor Tipu Aziz has been awarded the lifetime achievement award by the British Society for Stereotactic and Functional Neurosurgery (BSSFN) in May 2024.
Glowing dye helps surgeons eradicate prostate cancer
10 June 2024
A glowing marker dye that sticks to prostate cancer cells could help surgeons to remove them in real-time, according to a study led by the University of Oxford.
Highlights from the NDS Away Day
24 May 2024
On Thursday 9 May, the Nuffield Department of Surgical Sciences (NDS) held its best Away Day yet at St Catherine’s College in Oxford.
ARTICULATE PRO study releases new videos about the role of AI in prostate cancer diagnosis
22 May 2024
The ARTICULATE PRO study at the Nuffield Department of Surgical Sciences (NDS) has produced three videos highlighting the use of artificial intelligence (AI) to help pathologists in diagnosing prostate cancer.
Analysis identifies 50 new genomic regions associated with kidney cancer risk
7 May 2024
In a new analysis of genetic susceptibility to kidney cancer, an international team of researchers, including Professor Mark Sullivan from Oxford University's Nuffield Department of Surgical Sciences, has identified 50 new areas across the genome that are associated with the risk of developing kidney cancer.
New trial using skin patches as an ‘early warning system’ to spot lung transplant rejection
17 April 2024
A new trial, SENTINEL, is set to investigate if skin patches can be used as an early warning system to identify if lung transplants are being rejected, so treatment can begin sooner, reducing the chance of longer lasting organ damage.